Systematic Financial Management’s AstraZeneca AZN Stock Holding History

Systematic Financial Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-16,400	Closed	-$1.04M	–	640
2015 Q2	$1.04M	Hold	16,400	–	–	0.01%	618
2015 Q1	$1.12M	Hold	16,400	–	–	0.01%	605
2014 Q4	$1.15M	Hold	16,400	–	–	0.01%	599
2014 Q3	$1.17M	Sell	16,400 -8,000	-33%	-$586K	0.01%	620
2014 Q2	$1.81M	Hold	24,400	–	–	0.01%	594
2014 Q1	$1.58M	Hold	24,400	–	–	0.01%	628
2013 Q4	$1.45M	Sell	24,400 -1,900	-7%	-$103K	0.01%	594
2013 Q3	$1.36M	Hold	26,300	–	–	0.01%	580
2013 Q2	$1.24M	Buy	+26,300	New	+$1.34M	0.01%	580

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Systematic Financial Management's AZN Position: Q3 2015 in Review

Systematic Financial Management sold out of AstraZeneca (AZN) in Q3 2015, closing a stake of 16,400 shares — an estimated $1.04M sold.

Systematic Financial Management first reported a position in AZN in Q2 2013 and held it in 9 quarters. The position peaked at $1.81M in Q2 2014. 371 funds tracked by Wall St. Rank hold AZN as of Q3 2015.

Systematic Financial Management reported no remaining AstraZeneca position as of Q3 2015 after selling out during the quarter.
Systematic Financial Management sold 16,400 AstraZeneca shares in Q3 2015, an estimated $1.04M.
Systematic Financial Management first reported a position in AstraZeneca in Q2 2013 and held it in 9 quarters.
Systematic Financial Management's AstraZeneca position peaked at $1.81M in Q2 2014.
371 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2015.

Based on Systematic Financial Management's 13F filing for Q3 2015, filed 6 Nov 2015.